Initial Therapy for the Common Cold
Do not prescribe antibiotics for the common cold, as they provide no benefit and increase the risk of adverse effects; instead, offer symptomatic therapy with first-generation antihistamine/decongestant combinations or naproxen as first-line treatment in adults without contraindications. 1
Primary Treatment Approach
Antibiotics: Never Indicated
- Antibiotics are explicitly not recommended for the common cold, as they are ineffective against viral infections and significantly increase the risk of adverse effects 1
- The common cold is a self-limited viral illness that resolves without antimicrobial therapy, typically within 2 weeks 1, 2
- Antibiotics do not prevent complications such as acute bacterial sinusitis, asthma exacerbation, or otitis media 1
First-Line Symptomatic Therapy
For adults without contraindications, prescribe first-generation antihistamine/decongestant combinations or naproxen 220-440 mg as initial therapy. 1
- First-generation antihistamine/decongestant combinations provide significant symptom relief in 1 out of 4 patients treated 1
- Naproxen (a nonsteroidal anti-inflammatory drug) is strongly recommended by the American College of Chest Physicians unless contraindicated 1
- Newer-generation nonsedating antihistamines should NOT be used, as they are ineffective for cold symptoms 1
Important Contraindications to Consider
Before prescribing antihistamine/decongestant combinations or NSAIDs, screen for the following contraindications:
- For antihistamine/decongestants: glaucoma, benign prostatic hypertrophy, uncontrolled hypertension 1
- For naproxen/NSAIDs: renal failure, gastrointestinal bleeding history, congestive heart failure 1
- For NSAIDs in patients with asthma: Use with extreme caution, as cross-reactivity with aspirin can cause severe bronchospasm that can be fatal 3
Special Considerations for Comorbidities
Hypertension
- NSAIDs including naproxen can lead to new-onset hypertension or worsening of preexisting hypertension 3
- Blood pressure should be monitored closely if NSAIDs are used 3
- Decongestants (oral or topical) should be used cautiously, as they can elevate blood pressure 4
- Consider avoiding both NSAIDs and decongestants in poorly controlled hypertension; use simple analgesics like acetaminophen instead 5
Asthma or COPD
- Do not use NSAIDs in patients with aspirin-sensitive asthma, as severe bronchospasm can occur 3
- Use NSAIDs with extreme caution even in patients with non-aspirin-sensitive asthma 3
- Inhaled ipratropium bromide can relieve nasal symptoms and may be particularly useful in patients with underlying airway disease 1, 6
- Monitor closely for asthma exacerbation, which is a recognized complication of the common cold 1
- If cough worsens after initial improvement (biphasic course), consider bacterial sinusitis or other complications requiring different management 1
Heart Failure
- Avoid NSAIDs in patients with severe heart failure unless benefits clearly outweigh risks 3
- NSAIDs can cause fluid retention, edema, and worsening heart failure 3
- If NSAIDs must be used, monitor patients closely for signs of worsening heart failure 3
Additional Symptomatic Therapies
Effective Options
- Topical nasal decongestants (e.g., oxymetazoline) or oral decongestants (pseudoephedrine, phenylephrine) for up to 3 days only to relieve nasal congestion in adults 6, 4, 7
- Inhaled ipratropium bromide for rhinorrhea 1, 6
- Zinc supplements (acetate or gluconate) if started within 24 hours of symptom onset, though weigh benefits against adverse effects like nausea and bad taste 1, 7
- Simple analgesics (acetaminophen) for fever and discomfort 5
Ineffective Therapies to Avoid
- Vitamin C and echinacea have no proven benefit for treatment (though vitamin C prophylaxis may have modest effects) 1, 7
- Codeine has not been shown to effectively treat cough caused by the common cold 6
- Over-the-counter combination cold medications lack evidence unless they contain older antihistamine/decongestant ingredients 1
Critical Pitfalls to Avoid
Decongestant Overuse
- Limit topical nasal decongestants to 3 days maximum to prevent rebound congestion 6, 4
- Repeated doses of nasal decongestants over several days show no significant benefit over placebo 4
Duration and Follow-Up
- Advise patients that symptoms can last up to 2 weeks 1
- Instruct patients to follow up if symptoms worsen after initial improvement or exceed 2 weeks, as this may indicate bacterial complications requiring antibiotics 1
- A biphasic course (initial improvement followed by worsening) suggests bacterial sinusitis or pertussis 1
Patient Education
- Emphasize that handwashing is the most effective method to reduce transmission 1
- Reassure patients that antibiotics are not needed and may cause harm 1
- Explain that the common cold affects only the upper respiratory tract in otherwise healthy adults, with no clinically important lower respiratory tract involvement 2